Results 101 to 110 of about 506,611 (220)

Potential serotype coverage of three pneumococcal conjugate vaccines against invasive pneumococcal infection in Italian children

, 2012
Since the introduction of the 7-valent vaccine, invasive pneumococcal disease have greatly decreased; however, changes in the distribution of pneumococcal serotypes have recently highlighted the need for vaccines with wider coverage.
Valleriani, Claudia, Indolfi, Giuseppe, Azzari, Chiara, Cortimiglia, Martina, Ricci, Silvia, Massimo Resti, de Martino, Maurizio, Resti, Massimo, Francesco Nieddu, Maurizio de Martino, Chiara Azzari, Nieddu, Francesco, Moriondo, Maria, Canessa, Clementina, Maria Moriondo, LANARI, MARCELLO, Giuseppe Indolfi, Claudia Valleriani, ], Martina Cortimiglia, Silvia Ricci, Italian group for the study of Invasive Pneumococcal Disease [, Clementina Canessa   +22 more
core   +1 more source

Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysis

Health Technology Assessment
Background Vaccination of infants with pneumococcal conjugate vaccines is recommended by the World Health Organization. Evidence is mixed regarding the differences in immunogenicity and efficacy of the different pneumococcal vaccines.
Shuo Feng, Julie McLellan, Nicola Pidduck, Nia Roberts, Julian PT Higgins, Yoon Choi, Alane Izu, Mark Jit, Shabir A Madhi, Kim Mulholland, Andrew J Pollard, Simon Procter, Beth Temple, Merryn Voysey   +13 more
doaj   +1 more source

Pneumococcal conjugate vaccine (PCV13) : what you need to know [Turkish]

Pneumococcal conjugate vaccine (PCV13) : what you need to know [Turkish]Pneumococcal conjugate (PCV13) VIS \u2013 Turkish (8/6/21)turkish_pcv13 ...

core  

Indian Multidisciplinary Expert Opinions on the Use of 20-Valent Pneumococcal Conjugate Vaccine in Adults. [PDF]

Vaccines (Basel)
Koul PA, Dhar R, Balaji V, Ratnavelu VK, Guleria R, Khullar D, Sahay M, Ramasubramanian V, Kalra S, Venkitakrishnan R, Vora A, Tiwaskar M, Agarwal MB, Prabhash K, Oomman A, Gupta M, Ghosh S, Sharma RK, Deshpande R, Narreddy S, Srikantiah C, Dharmanand BG, Sanyal D, Puthanmadathil J, Agarwal S, Choudhari S, Taur S, Kulkarni N.   +27 more
europepmc   +1 more source

Recommendations for Adult Pneumococcal Vaccination in Korea: 2026 Update Incorporating the 21-Valent Pneumococcal Conjugate Vaccine. [PDF]

Infect Chemother
Song JY, Kwon KT, Park WB, Noh JY, Park SH, Choo EJ, Choi MJ, Choi JY, Heo JY, Choi WS, Committee of Adult Immunization in the Korean Society of Infectious Diseases.   +10 more
europepmc   +1 more source

Neutrophils induce effective antibody responses to the pneumococcal conjugate vaccine by inhibiting T regulatory cells. [PDF]

J Leukoc Biol
Tchalla EYI, Betadpur A, Khalil AY, Lopez E, Bhalla M, Chang M, Wohlfert EA, Bou Ghanem EN.   +7 more
europepmc   +1 more source

Pneumococcal conjugate vaccine (PCV13) : what you need to know [Spanish]

Pneumococcal conjugate vaccine (PCV13) : what you need to know [Spanish]PCV13 VIS \u2013 Spanish (8/6/21)spanish_pcv13 ...

core  

Adult Pneumococcal Vaccination in Latin America: The Next Step Beyond Pediatric Pneumococcal Conjugate Vaccine. [PDF]

Cureus
Zavaleta-Monestel E, Arguedas-Chacón S, Mora-Jiménez J, Díaz-Madriz JP, Herrera-Jiménez LG.   +4 more
europepmc   +1 more source

Pneumococcal conjugate vaccine (PCV13) : what you need to know [French]

Pneumococcal conjugate vaccine (PCV13) : what you need to know [French]PCV13 VIS \u2013 French (8/6/21)french_pcv13 ...

core  

Association between introduction of 13-valent pneumococcal conjugate vaccine and burden of hospitalized adult pneumococcal disease in Taiwan - a retrospective database study. [PDF]

Epidemiol Infect
Wang CC, Yen TA, Wu JL, Huang LY, Yeo SH, Patel D, Lim C, Lin HW, Yamada E, Sukarom I.   +9 more
europepmc   +1 more source